Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order

TNC / Tenascin C

tenascin C

Tenascin C (TNC) is the founding member of the gene family. In the embryo it is made by migrating cells like the neural crest; it is also abundant in developing tendons, bone and cartilage. The basic structure is 14 EGF-like repeats towards the N-terminal end, and 8 or more fibronectin-III domains which vary upon species and variant. TNC has anti-adhesive properties, causing cells in tissue culture to become rounded after it is added to the medium. One mechanism to explain this may come from its ability to bind to the extracellular matrix glycoprotein fibronectin and block fibronectin's interactions with specific syndecans. The expression of tenascin-C in the stroma of certain tumors is associated with a poor prognosis.

Gene Name: tenascin C
Family/Subfamily: Fibronectin , not assigned-Fibronectin
Synonyms: TNC, 150-225, Cytotactin, GP, Hexabrachion (tenascin), GMEM, GP 150-225, Miotendinous antigen, Myotendinous antigen, JI, Tenascin, Tenascin C, Neuronectin, Tenascin-C isoform 14/AD1/16, TN-C, Hexabrachion, HXB, Tenascin-C, TN
Target Sequences: NM_002160 NP_002151.2 P24821

Publications (15)

1
Involvement of large tenascin-C splice variants in breast cancer progression. Tsunoda T, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R, Katsuta K, Sakakura T, Majima Y, Yoshida T. The American journal of pathology. 2003 162:1857-67. [PubMed:12759243] [PMC:PMC1868127]
2
Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Tamaoki M, Imanaka-Yoshida K, Yokoyama K, Nishioka T, Inada H, Hiroe M, Sakakura T, Yoshida T. The American journal of pathology. 2005 167:71-80. [PubMed:15972953] [PMC:PMC1603439]
3
Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion. Kriinen E, Nummela P, Soikkeli J, Yin M, Lukk M, Jahkola T, Virolainen S, Ora A, Ukkonen E, Saksela O, Hltt E. The Journal of pathology. 2006 210:181-91. [PubMed:16924594]
4
Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C. El-Karef A, Kaito M, Tanaka H, Ikeda K, Nishioka T, Fujita N, Inada H, Adachi Y, Kawada N, Nakajima Y, Imanaka-Yoshida K, Yoshida T. Journal of hepatology. 2007 46:664-73. [PubMed:17188391]
5
B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder?. Richter P, Tost M, Franz M, Altendorf-Hofmann A, Junker K, Borsi L, Neri D, Kosmehl H, Wunderlich H, Berndt A. Journal of cancer research and clinical oncology. 2009 135:1351-8. [PubMed:19326143]
6
Increased presence of stromal myofibroblasts and tenascin-C with malignant progression in canine mammary tumors. Yoshimura H, Michishita M, Ohkusu-Tsukada K, Takahashi K. Veterinary pathology. 2011 48:313-21. [PubMed:20571146]
7
Expression of tenascin-C and its isoforms in the breast. Guttery DS, Shaw JA, Lloyd K, Pringle JH, Walker RA. Cancer metastasis reviews. 2010 29:595-606. [PubMed:20814719]
8
A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. Balasenthil S, Chen N, Lott ST, Chen J, Carter J, Grizzle WE, Frazier ML, Sen S, Killary AM. Cancer prevention research (Philadelphia, Pa.). 2011 4:137-49. [PubMed:21071578]
9
Regeneration of the perineurium after microsurgical resection examined with immunolabeling for tenascin-C and alpha smooth muscle actin. Yamamoto M, Okui N, Tatebe M, Shinohara T, Hirata H. Journal of anatomy. 2011 218:413-25. [PubMed:21265831] [PMC:PMC3077524]
10
Novel effects of CCN3 that may direct the differentiation of chondrocytes. Janune D, Kubota S, Nishida T, Kawaki H, Perbal B, Iida S, Takigawa M. FEBS letters. 2011 585:3033-40. [PubMed:21871891]
11
Promoting effects of carminic acid-enriched cochineal extracts on capsular invasive thyroid carcinomas through targeting activation of angiogenesis in rats. Kemmochi S, Shimamoto K, Shiraki A, Onda N, Hasumi K, Suzuki K, Mitsumori K, Shibutani M. The Journal of toxicological sciences. 2012 37:475-82. (IHC; Rat) [PubMed:22687987]
12
Lac color inhibits development of rat thyroid carcinomas through targeting activation of plasma hyaluronan-binding protein. Kemmochi S, Yamamichi S, Shimamoto K, Onda N, Hasumi K, Suzuki K, Mitsumori K, Shibutani M. Experimental biology and medicine (Maywood, N.J.). 2012 237:728-38. (IHC; Rat) [PubMed:22715430]
13
Direct progression of capsular invasive carcinomas from subcapsular focal hyperplasias induced by hypothyroidism-mediated tumor promotion in a rat two-stage thyroid carcinogenesis model. Ago K, Kemmochi S, Morita R, Yafune A, Shiraki A, Mitsumori K, Shibutani M. Journal of cancer research and clinical oncology. 2013 139:395-401. (IHC; Rat) [PubMed:23114882]
14
Tenascin-C inactivation impacts lung structure and function beyond lung development. Sandrine Gremlich, Matthias Roth-Kleiner, Lucile Equey, Kleanthis Fytianos, Johannes C Schittny, Tiziana P Cremona. Scientific reports. 2020 Mar;10:5118. [Full Text Article] [PubMed:32198404] [PMC:PMC7083919]
15
Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreatic Cancer. Mohammad Azhar Kamal, Imran Siddiqui, Cristina Belgiovine, Marialuisa Barbagallo, Valentina Paleari, Daniela Pistillo, Chiara Chiabrando, Silvia Schiarea, Barbara Bottazzi, Roberto Leone, Roberta Avigni, Roberta Migliore, Paola Spaggiari, Francesca Gavazzi, Giovanni Capretti, Federica Marchesi, Alberto Mantovani, Alessandro Zerbi, Paola Allavena. Cancers. 2022 May;14: [Full Text Article] [PubMed:35681634] [PMC:PMC9179463]
more

☰ Filters
Products
Proteins (10)
Over-Expression Lysate (2)
Recombinant (8)
TNC / Tenascin C (10)
No (10)
GST, N-terminus (1)
His (4)
His, N-Terminal (2)
Myc-DDK (Flag) (3)
Human (5)
Mouse (1)
Rat (3)
293T Cells (1)
E. coli (6)
HEK 293 Cells (2)
Wheat Germ Extract (1)
Purified (3)
TNC / Tenascin C Protein - Recombinant  Tenascin C By SDS-PAGE
Select
E. coli
His, N-Terminal
51.8 kDa
10 µg/$279; 50 µg/$432; 100 µg/$690; 200 µg/$862; 1 mg/$1,962; 500 µg/$1,505; 5 mg/$3,011; 2 mg/$2,148
Select
E. coli
His
39.6 kD
20 µg/$323; 1 mg/$1,355; 100 µg/$420
TNC / Tenascin C Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
293T Cells
Myc-DDK (Flag)
240.91 kDa
20 µg/$215
TNC / Tenascin C Protein - Recombinant Tenascin C By SDS-PAGE
Select
E. coli
His, N-Terminal
19.5 kDa
10 µg/$283; 50 µg/$452; 100 µg/$722; 200 µg/$902; 1 mg/$2,016; 500 µg/$1,553; 5 mg/$3,151; 2 mg/$2,204
TNC / Tenascin C Protein - Recombinant Tenascin C By SDS-PAGE
Select
E. coli
His
16.6 kDa
10 µg/$283; 50 µg/$452; 1 mg/$2,016; 200 µg/$902; 100 µg/$722; 500 µg/$1,553; 5 mg/$3,151; 2 mg/$2,204
TNC / Tenascin C Protein - 12.5% SDS-PAGE Stained with Coomassie Blue.
Select
Wheat Germ Extract
GST, N-terminus
10 µg/$479; 25 µg/$670
TNC / Tenascin C Protein - Purified recombinant protein TNC was analyzed by SDS-PAGE gel and Coomassie Blue Staining
Select
HEK 293 Cells
Myc-DDK (Flag)
238.6 kDa
20 µg/$1,107
TNC / Tenascin C Protein - Recombinant Tenascin C By SDS-PAGE
Select
E. coli
His
15.8 kDa
10 µg/$278; 50 µg/$422; 100 µg/$672; 200 µg/$842; 1 mg/$1,934; 500 µg/$1,480; 5 mg/$2,941; 2 mg/$2,119
TNC / Tenascin C Protein - Recombinant Tenascin C By SDS-PAGE
Select
E. coli
His
13.0 kDa
10 µg/$283; 50 µg/$452; 100 µg/$722; 200 µg/$902; 1 mg/$2,016; 500 µg/$1,553; 5 mg/$3,151; 2 mg/$2,204
TNC / Tenascin C Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
HEK 293 Cells
Myc-DDK (Flag)
240.91 kDa
100 µg/$710
Viewing 1-10 of 10 product results


Filtered By:
Products: Proteins


If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.

PLEASE NOTE

For RESEARCH USE ONLY. Intended for use by laboratory professionals. Not intended for human diagnostic or therapeutic purposes.

The data on this page has been compiled from LifeSpan internal sources, the National Center for Biotechnology Information (NCBI), and The Universal Protein Resource (UniProt).